These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33319329)

  • 41. The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes.
    Mah PT; O'Connell P; Focaroli S; Lundy R; O'Mahony TF; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
    Eur J Pharm Biopharm; 2019 Nov; 144():139-153. PubMed ID: 31536784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
    Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spray-dried amorphous isomalt and melibiose, two potential protein-stabilizing excipients.
    Lipiäinen T; Peltoniemi M; Räikkönen H; Juppo A
    Int J Pharm; 2016 Aug; 510(1):311-22. PubMed ID: 27321131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders.
    Maa YF; Nguyen PA; Andya JD; Dasovich N; Sweeney TD; Shire SJ; Hsu CC
    Pharm Res; 1998 May; 15(5):768-75. PubMed ID: 9619788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules.
    Sou T; Kaminskas LM; Nguyen TH; Carlberg R; McIntosh MP; Morton DA
    Eur J Pharm Biopharm; 2013 Feb; 83(2):234-43. PubMed ID: 23183447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.
    Vandenheuvel D; Meeus J; Lavigne R; Van den Mooter G
    Int J Pharm; 2014 Sep; 472(1-2):202-5. PubMed ID: 24950368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
    Yu J; Romeo MC; Cavallaro AA; Chan HK
    Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-Solvent Microdroplet Evaporation: Modeling and Measurement of Spray-Drying Kinetics with Inhalable Pharmaceutics.
    Ordoubadi M; Gregson FKA; Melhem O; Barona D; Miles REH; D'Sa D; Gracin S; Lechuga-Ballesteros D; Reid JP; Finlay WH; Vehring R
    Pharm Res; 2019 May; 36(7):100. PubMed ID: 31089892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leucine enhances the dispersibility of trehalose-containing spray-dried powders on exposure to a high-humidity environment.
    Wang Z; Wang H; Vehring R
    Int J Pharm; 2021 May; 601():120561. PubMed ID: 33811968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation into the effect of varying l-leucine concentration on the product characteristics of spray-dried liposome powders.
    Chen KH; Mueannoom W; Gaisford S; Kett VL
    J Pharm Pharmacol; 2012 Oct; 64(10):1412-24. PubMed ID: 22943172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Buffer Salts on Physical Stability of Lyophilized and Spray-Dried Protein Formulations Containing Bovine Serum Albumin and Trehalose.
    Mutukuri TT; Ling J; Du Y; Su Y; Zhou QT
    Pharm Res; 2023 Jun; 40(6):1355-1371. PubMed ID: 35764755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spray freeze drying to solidify Nanosuspension of Cefixime into inhalable microparticles.
    Haghighi DM; Faghihi H; Darabi M; Mirmoeini MS; Vatanara A
    Daru; 2022 Jun; 30(1):17-27. PubMed ID: 34997567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A; Boireau H; Horta MJ; Vanbever R
    Eur J Pharm Biopharm; 2008 Nov; 70(3):839-44. PubMed ID: 18620052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles.
    Fini A; Ospitali F; Zoppetti G; Puppini N
    Pharm Res; 2008 Sep; 25(9):2030-40. PubMed ID: 18597163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bacteriophage Encapsulation Using Spray Drying for Phage Therapy.
    Malik DJ
    Curr Issues Mol Biol; 2021; 40():303-316. PubMed ID: 32678066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interplay between trehalose and dextran as spray drying precursors for cationic liposomes.
    Lutta A; Knopp MM; Tollemeto M; Pedersen GK; Schmidt ST; Grohganz H; Hagner Nielsen L
    Int J Pharm; 2024 Mar; 652():123798. PubMed ID: 38190949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery.
    Hoe S; Ivey JW; Boraey MA; Shamsaddini-Shahrbabak A; Javaheri E; Matinkhoo S; Finlay WH; Vehring R
    Pharm Res; 2014 Feb; 31(2):449-65. PubMed ID: 23974958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs.
    Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H
    Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.